Association between bone mineral density and hearing loss in Osteogenesis Imperfecta

Similar documents
Audiologic and Genetic Determination of Hearing Loss in Osteogenesis Imperfecta

Temporal bone imaging in osteogenesis imperfecta patients with hearing loss

Fluoride As a Nutrient of Public Health Importance

Temporal Bone Imaging in Osteogenesis Imperfecta Patients With Hearing Loss

Peripheral quantitative computed tomography of the distal radius in young subjects new reference data and interpretation of results

Hearing Loss in Osteogenesis Imperfecta: Characteristics and Treatment Considerations

Thickness Computation Under In-Vivo Trabecular Bone CT Imaging

Beyond BMD: Bone Quality and Bone Strength

CT Imaging of skeleton in small animals. Massimo Marenzana

Imaging to Assess Bone Strength and its Determinants

A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY. Julie Marie Cousins

THE PENNSYLVANIA STATE UNIVERSITY SCHREYER HONORS COLLEGE DEPARTMENT OF SCIENCE

Product: Denosumab (AMG 162) Clinical Study Report: month Primary Analysis Date: 21 November 2016 Page 1

Adina Alazraki, MD, FAAP Assistant Professor, Radiology and Pediatrics Emory University School of Medicine Children s Healthcare of Atlanta

HEARING. Structure and Function

Chapter 143: Otosclerosis (OS) Sameer Ahmed 2/23/2011

Newborn with Fractures. Payal Patel, M.D. Pediatric Endocrinology Fellow May 22, 2014

ADOLESCENT OBESITY: IS IT BAD FOR THE BONES

Patients with diffuse idiopathic skeletal hyperostosis do not have increased peripheral bone mineral density and geometry

Author's response to reviews

Audiology (Clinical Applications)

OSTEOPOROSIS AND SARCOPENIA IN OLDER ADULTS. Didier Chalhoub. B.S. in Biology, American University of Beirut, Lebanon, 2007

Hearing loss and fluctuating hearing levels in X-linked hypophosphataemic osteomalacia

Bimodal listening or bilateral CI: When and why?

Bone mineral density in pediatric inflammatory bowel disease

Bone density and size in ambulatory children with cerebral palsy

European Journal of Medicine, 2015, Vol.(10), Is. 4

LUMBAR IS IT IMPORTANT? S. Tantawy,, M.D.

The Use of Bisphosphonates in Increasing Bone Mineral Density and Decreasing Fracture Occurrence in Children with Osteogenesis Imperfecta

Bone geometry and volumetric bone mineral density in girls with Turner syndrome of different pubertal stages

JBMR. Osteoporotic fracture is a global public health concern

Beyond BMD: Bone Quality and Bone Strength

The bone mass concept: problems in short stature

Audiology. Anita Gáborján MD, PhD.

Disclosures. Beyond BMD: Bone Quality & Bone Strength. Design of a Structure. Fractures = structural failure of the skeleton

Journal of American Science 2017;13(12) Hearing Function in Osteoporotic Patients.

Bone Densities and Bone Size at the Distal Radius in Healthy Children and Adolescents: A Study Using Peripheral Quantitative Computed Tomography

This is a repository copy of Microarchitecture of bone predicts fractures in older women.

Acoustic Immittance (ME measures) Tympanometery

Finite Element Model of the Stapes-Inner Ear Interface

Mineral Density Of Subchondral Bone May Be Quantitatively Evaluated Using A Clinical Cone Beam Computed Tomography Scanner

KEYWORDS: bone strength exercise lifespan physical activity Heather M Macdonald 1, Maureen C Ashe 2,3 & Heather A McKay 2,3,4

Phenotype of the First Otosclerosis Family Linked to OTSC10

Kobe University Repository : Kernel

Audiology Lunch & Learn DR. BRANDI R. SHEPARD

POSITION PAPER. Osteoporos Int (2016) 27: DOI /s

Basic Audiogram Interpretation

Rahel Meinen, Inna Galli-Lysak, Peter M. Villiger and Daniel Aeberli *

Anabolic Therapy With Teriparatide Indications Beyond Osteoporosis

Injury Risk Assessment of the Femur in Children with Osteogenesis Imperfecta

Modélisation par éléments finis des effets des médicaments sur le remodelage osseux : Approche mécanobiologique

Supplementary appendix

Bone Stimulators and Their Use in Horses and People

Vitamins, Fatty Acids, Physical Activity and Peak Bone Mass. Magnus Högström

Audiological Evaluation of Affected Members from a Dutch DFNA8/12 (TECTA) Family

Name of Active Ingredient: Fully human monoclonal antibody to receptor activator for nuclear factor-κb ligand

Validation of in vivo cancellous bone assessment using high resolution imaging and histologic examination

Sex steroids are important for skeletal development

Bone turnover markers and prediction of bone loss in elderly women

Bone Densitometry Radiation dose: what you need to know

Stefano Stagi 1*, Loredana Cavalli 2, Tiziana Cavalli 3, Maurizio de Martino 1 and Maria Luisa Brandi 2

Building Bone Density-Research Issues

Beyond BMD: Bone Quality and Bone Strength

Pediatric metabolic bone diseases

Greater Polar Moment of Inertia at the Tibia in Athletes Who Develop Stress Fractures

COCHLEAR IMPLANTS Aetiology of Deafness. Bruce Black MD

EVALUATION OF THE CORTICAL BONE THICKNESS IN LUMBAR VERTEBRA USING CT AND RP EXPERIMENTAL TECHNIQUES

Risedronate in the Treatment of Mild Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study

Prevalence of Osteoporosis p. 262 Consequences of Osteoporosis p. 263 Risk Factors for Osteoporosis p. 264 Attainment of Peak Bone Density p.

A Novel Murine Model Of Adynamic Bone Disease (ABD)

2013 ISCD Combined Official Positions

OSTEOPOROSIS IN MEN is a major public health problem

Low serum vitamin D is associated with higher cortical porosity in elderly men

Auditory Functions In Oto-Palato-Digital Syndrome

Disclosures CONSULTANT WRIGHT MEDICAL CONSULTANT ORTHO FIX

Assessment and Treatment of Osteoporosis Professor T.Masud

CLINICAL DENSITOMETRY

Hearing is one of the most important special senses

ORIGINAL ARTICLE. A. González-Agüero & G. Vicente-Rodríguez & A. Gómez-Cabello & J. A. Casajús

Educational Module Tympanometry. Germany D Germering

Auditory Physiology Richard M. Costanzo, Ph.D.

Otosclerosis and Disorders of the Otic Capsule Ahmad M Alamadi FRCS (Glasg), Jerry Halik FRCS(C)

Anatomy of the ear: Lymphatics

Third-generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long-term follow-up

Otosclerosis. Diagnosis, Evaluation, Pathology, Surgical Techniques, and Outcomes

THE EFFECTS OF MULTIPLE UNLOADING EXPOSURES ON BONE PROPERTIES IN THE FEMUR OF ADULT MALE RATS. A Thesis DERRICK SCOTT MORGAN

Bone Mineral Densitometry with Dual Energy X-Ray Absorptiometry

Teriparatide for osteoporosis: importance of the full course

High-Impact Mechanical Loading Increases Bone Material Strength in Postmenopausal Women A 3-Month Intervention Study

New Dual-energy X-ray Absorptiometry Machines (idxa) and Vertebral Fracture Assessment

Chapter 39: Exercise prescription in those with osteoporosis

Changes in volumetric BMD of radius and tibia upon antidepressant drug administration in young depressive patients

Very far-advanced otosclerosis: stapedotomy or cochlear implantation

denosumab (Prolia ) Policy # Original Effective Date: 07/21/2011 Current Effective Date: 04/19/2017

Increased Cortical Porosity in Older Men With Fracture

Based on review of available data, the Company may consider the use of denosumab (Prolia) for the

Pediatric providers strive for insight into both bone

Introduction CASE REPORTS. Milan Erdoglija 1, Jelena Sotirovic 1, Violeta Jacimovic 1, Biserka Vukomanovic 2

2013 ISCD Official Positions Adult

BIOLOGY and BIOMECHANICS OF NORMAL & OSTEOPOROTIC BONE

Transcription:

Association between bone mineral density and hearing loss in Osteogenesis Imperfecta F Swinnen 1 E De Leenheer 1 S Goemaere 2 P Coucke 3 C Cremers 4 I Dhooge 1 (1) Departement of Otorhinolaryngology, Ghent University (Hospital) (2) Department of Endorinology & Rheumatology, Unit Osteporosis & Metabolic Bone Diseases, Ghent University Hospital (3) Center for Medical Genetics, Ghent University Hospital (4) Department of Otorhinolaryngology, Radboud University Nijmegen Medical Center

I. Introduction Osteogenesis Imperfecta (OI) - Hearing loss 2/16 50 % of OI patients OI types I, III, IV Mild to profound hearing loss, progressive Intrafamilial variability Hearing loss type: Conductive hearing loss Mixed hearing loss Pure high-frequency sensorineural hearing loss Pure sensorineural hearing loss

I. Introduction OI - Hearing loss (2) Mixed hearing loss 3/16 Conductive hearing loss Sensorineural hearing loss

I. Introduction OI - Hearing loss (3) 4/16 Conductive Mixed Pure sensorineural loss Otosclerosis-like lesions: stapes footplate fixation (and pericochlear lesions) Cochlear hair cell atrophy Atrophy stria vascularis Ossicular discontinuity (fractured/atrophic ossicles) Perilymphe hemorrhage

I. Introduction Computed tomography temporal bones 5/16 Bilaterally severely progressed mixed hearing loss in a 67-year old OI-patient: severe pericochlear demineralization of bone

I. Introduction Research aim 6/16 Relationship between occurrence/type of hearing loss and generalized bone disease? Heterogeneity of hearing loss explained by variability in bone characteristics?

II. Methods Patients and materials 7/16 56 adult OI patients (F: 34 M: 22) with identified mutation in COL1A1 or COL1A2 Mean age: 43 y. (SD 13.7) Bisphosphonates administration excluded Audiological evaluation Pure-tone audiometry Admittance measurements Stapedius reflex measurements Bone mineral density (BMD) measurements

II. Methods Bone mineral density measurements Dual X-ray absorptiometry (DXA): areal BMD (abmd) Lumbar spine trabecular bone abmd 8/16 Whole body cortical bone abmd Peripheral quantitative computed tomography (pqct): volumetric BMD (vbmd) Radial metaphysis (4%) trabecular bone vbmd Radial diaphysis (66%) cortical bone vbmd 4% 66% bone geometry parameters: cortical thickness, periosteal circumference, endosteal circumference

III. Results Audiological phenotype 9/16 60 50 40 40% 46% 14% 30 20 10 0 44 3 24 25 12 4

III. Results Hearing loss as a function of OI type and genotype in 56 OI patients 10/16 sensorineural conductive/mixed normal 60 50 60 50 40 40 30 30 20 20 10 10 0 COL1A1 COL1A1 COL1A2 quantitative qualitative qualitative 0 OI type I OI type IV No association between hearing loss and mutated gene, type I collagen defect or OI type

abmd Z- score III. Results Hearing loss as a function of abmd (DXA) 11/16 DXA Lumbar spine DXA Whole body Normal Conductive/ mixed Normal Conductive/ mixed Sensorineural Sensorineural (N=19) (N=29) (N=8) (N=19) (N=29) (N=8) Mean z-scores < 0 (except sensorineural losses) ANCOVA [gender, weight, type I collagen defect] : sensorineural hearing loss > conductive/mixed hearing loss and normal hearing (P<0.05)

Trabecular vbmd Z- score III. Results Hearing loss as a function of vbmd (pqct) Cortical vbmd (mg/mm 3 ) 12/16 pqct radial metaphysis: trabecular bone pqct radial diaphysis: cortical bone Normal Conductive/ mixed Normal Conductive/ mixed ANCOVA [gender, age, type I collagen defect] for (trabecular vbmd z-score *hearing): conductive/mixed hearing loss < normal and sensorineural hearing loss Radial diaphysis: no differences in cortical vbmd or bone geometry parameters Sensorineural Sensorineural (N=19) (N=29) (N=8) (N=19) (N=29) (N=8)

III. Results Between-relatives comparisons of BMD and hearing 13/16 Family number Family number OI patients with conductive/mixed hearing loss have lower BMD compared to their normal hearing relatives with OI

IV. Discussion 14/16 OI patients with conductive/mixed hearing loss have lower BMD than patients with normal hearing or pure sensorineural loss OI patients with pure sensorineural hearing loss have higher abmd than patients with normal hearing or conductive/mixed hearing loss (small sample + highest mean age) No differences in volumetric cortical bone mineral density or bone geometry parameters measured at radial diaphysis:! Cortical vbmd: unreliable parameter when cortical thickness < 2.0 mm (spatial resolution too low)

V. Discussion 15/16 Temporal bone: Cortical bone Bone formation complete at age 1 year Bone remodeling is minimal Association conductive/mixed hearing loss and lower BMD: accumulating microfractures and fatigue microdamage destruct the osteoprotegerin (OPG) pathways which regulate temporal bone remodeling inhibition? Future perspectives: Replication in large population Histological investigations of OI temporal bones Effects of bisphosphonates on hearing in OI

16/16